Tag: Psoriasis
Guideline Covers Extracutaneous Manifestations of Psoriasis
Second guideline presents evidence for different biologic agents, including adverse events
Psoriasis Tx Linked to Drop in Noncalcified Coronary Plaque
Noncalcified plaque burden and necrotic core reduced in association with biologic therapy
Methotrexate Well Tolerated, Effective for Psoriasis in Chinese
Greater therapeutic response, fewer adverse events seen in those without psoriatic arthritis
Hypertension With Psoriasis Tied to More Cardiac Interventions
In patients with hypertension, psoriasis linked to increased risk for cardiovascular procedures, surgeries
Classification of Psoriasis Severity Depends on Definition
Authors call for international standardization defining moderate-to-severe psoriasis
Recommendations Developed for Psoriatic Arthritis Treatment
Guideline includes use of treat-to-target strategy for all adult patients with active PsA
Higher Cardiovascular Risk Seen With Psoriatic Arthritis
Risk seems to be increased especially in patients with a high inflammatory burden, late-onset psoriasis
Novel Scoring System Can Up Access to Biologics in Psoriasis
DLQI-R allows more patients to achieve threshold for becoming candidates for biologic treatment
Psoriasis Linked to Increased Risk for Inflammatory Bowel Disease
Significant associations observed between psoriasis and risk for Crohn's disease, ulcerative colitis
Halobetasol Propionate Lotion Shows Efficacy for Tx of Psoriasis
Findings based on two phase 3 trials of halobetasol propionate lotion versus vehicle
